Future Shaper Holdings

Shaper Therapeutics, operating under the parent entity Future Shaper Holdings, is a biotechnology company focused on the discovery and development of small molecule drugs that target RNA and RNA-binding proteins (RBPs). The company utilizes a proprietary platform that integrates structural biology, computational chemistry, and high-throughput screening to identify novel ways to modulate RNA processing and translation. Their primary therapeutic focus is on oncology and rare genetic disorders where RNA dysregulation is a key driver of disease. Based in Cambridge, Massachusetts, Shaper Therapeutics aims to unlock previously undruggable targets by focusing on the post-transcriptional regulation of the human genome.